ARTG 440750Non-sterile scar management dressing, single-use
ARTG ID: 440750 · JD Healthcare Group Pty Ltd · Biodermis · Class I · Started February 13, 2024
Good Name: JD Healthcare Group Pty Ltd - Non-sterile scar management dressing, single-use
- Risk Class
- Class I
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 440750
- Start Date
- February 13, 2024
- Effective Date
- February 13, 2024
- Name
- Biodermis
- Country
- United States of America
- Address
- Suite 1 / 3078 East Sunset Road, LAS VEGAS, NV, 89120
Xeragel is practical, convenient 100% silicone for scars. It is highly recommended for use on exposed (not under clothing) scars. Xeragel is a 100% silicone gel scar treatment, designed for convenient, regular application over small scars. Perfect for discreet application on scar treatment sites where sheets would be inconvenient, impractical, or unsightly. Xeragel is a spreadable silicone ointment that is completely transparent.
Access comprehensive regulatory information for Non-sterile scar management dressing, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is registered under ARTG number 440750 and sponsored by JD Healthcare Group Pty Ltd, manufactured by Biodermis in United States of America. The device registration started on February 13, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.